对于脑疾病的精准医学而言,基因疗法是基因疗法
Yang Liu1,2, Linlin Fan2, Haoying Yang2
1Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, China.
Frontiers in nutrition
|March 7, 2024
概括
性饮食 (KD) 通过改变新陈代谢,显示出对各种疾病的治疗潜力. 对其机制和各种反应的进一步研究对于个性化的营养疗法至关重要.
科学领域:
- 营养科学 营养科学
- 代谢障碍 代谢障碍 代谢障碍
- 神经科学是一个神经科学.
背景情况:
- 精准营养和营养基因组学正在推进疾病治疗.
- 高脂肪和低碳水化合物食 (KD) 通过产生子来改变患者的新陈代谢.
- 在神经,瘤和代谢疾病中,KD显示出治疗前景.
研究的目的:
- 审查当前代饮食 (KD) 治疗方面的进展.
- 讨论KD反应的异质性.
- 从精准营养的角度探索KD的治疗前景.
主要方法:
- 关于性饮食疗法的当前研究的文献综述.
- 对调查KD对新陈代谢和疾病影响的研究进行分析.
- 检查影响KD反应变异性的因素.
主要成果:
- 肯德基已经在各种疾病,特别是神经疾病中表现出治疗效果.
- 确切的KD治疗机制尚未完全理解.
- 在不同人群对KD的反应方面存在显著的异质性.
结论:
- 了解子代谢对于开发基于KD和协同疗法至关重要.
- 需要个性化的方法来优化KD的疗效.
- 需要进一步的研究来阐明KD机制和个人对精密营养的反应.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


